CorMedix Inc.
CRMD
$8.65
$0.111.29%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 953.61% | 1,009.40% | 452.12% | 196.32% | 134.20% |
| Total Depreciation and Amortization | 5,437.78% | 4,593.26% | 2,081.37% | 296.60% | 494.72% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 63.00% | -259.41% | -865.77% | 46.48% | 27.66% |
| Change in Net Operating Assets | 46.11% | 118.44% | -170.73% | -676.02% | -3,681.23% |
| Cash from Operations | 1,557.07% | 445.84% | 234.49% | 159.98% | 70.07% |
| Capital Expenditure | -4,504.02% | -1,848.10% | -36.83% | 86.62% | 82.69% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -48.83% | -89.03% | -106.56% | -191.74% | 75.06% |
| Cash from Investing | -2,624.75% | -1,552.74% | -1,509.82% | -194.51% | 84.04% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 168.72% | 262.84% | 556.16% | 160.34% | -31.06% |
| Repurchase of Common Stock | -1,021.21% | -585.52% | -654.02% | -457.86% | -310.12% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 577.54% | 806.01% | 1,520.17% | 158.75% | -33.14% |
| Foreign Exchange rate Adjustments | 83.33% | 90.00% | -121.05% | 50.00% | -300.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 263.13% | 3,525.91% | 177.81% | 1,393.47% | 214.62% |